Keen Eye is developing an image analysis platform as well as AI algorithms for preclinical and clinical research. Keen Eye enables physicians and biologists to replicate and extend their visual expertise, identifying signals with high predictive value that are difficult to detect. They save precious time in decision-making, whether it is to diagnose, screen for a disease or assess the effectiveness of a drug, in a more precise and standardized way.
74 Rue du Faubourg Saint-Antoine, 75012 Paris
Targeted indications : breast cancer, lung cancer, colorectal cancer, prostate cancer, stomach cancer, supportive care, liver cancer, brain cancer, head & neck cancer, gastrointestinal cancer, gynecological cancer, bone cancer, genitourinary cancer, skin cancer, hematologic cancer, lymphoma, myeloma, leukemia, predictive toxicology.